BRPI0821580A2 - Agente para o tratamento de úlcera, uso da hidrotalcita compósita particulada, compromido para o tratamento de úlcera, agente granular ou um agente granular fino, agente em pasta fluída para tratar úlcera, agente para o fornemcimentode zinco, e, método para o tratamento de úlcera péptica. - Google Patents

Agente para o tratamento de úlcera, uso da hidrotalcita compósita particulada, compromido para o tratamento de úlcera, agente granular ou um agente granular fino, agente em pasta fluída para tratar úlcera, agente para o fornemcimentode zinco, e, método para o tratamento de úlcera péptica.

Info

Publication number
BRPI0821580A2
BRPI0821580A2 BRPI0821580-4A BRPI0821580A BRPI0821580A2 BR PI0821580 A2 BRPI0821580 A2 BR PI0821580A2 BR PI0821580 A BRPI0821580 A BR PI0821580A BR PI0821580 A2 BRPI0821580 A2 BR PI0821580A2
Authority
BR
Brazil
Prior art keywords
agent
ulcer
ulcer treatment
treatment
granular
Prior art date
Application number
BRPI0821580-4A
Other languages
English (en)
Inventor
Keiko Katsuki
Akira Okada
Original Assignee
Kyowa Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd
Publication of BRPI0821580A2 publication Critical patent/BRPI0821580A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821580-4A 2007-12-10 2008-12-04 Agente para o tratamento de úlcera, uso da hidrotalcita compósita particulada, compromido para o tratamento de úlcera, agente granular ou um agente granular fino, agente em pasta fluída para tratar úlcera, agente para o fornemcimentode zinco, e, método para o tratamento de úlcera péptica. BRPI0821580A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007318529 2007-12-10
JP2008118043 2008-04-30
PCT/JP2008/072016 WO2009075216A1 (ja) 2007-12-10 2008-12-04 潰瘍治療剤

Publications (1)

Publication Number Publication Date
BRPI0821580A2 true BRPI0821580A2 (pt) 2015-06-16

Family

ID=40755460

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821580-4A BRPI0821580A2 (pt) 2007-12-10 2008-12-04 Agente para o tratamento de úlcera, uso da hidrotalcita compósita particulada, compromido para o tratamento de úlcera, agente granular ou um agente granular fino, agente em pasta fluída para tratar úlcera, agente para o fornemcimentode zinco, e, método para o tratamento de úlcera péptica.

Country Status (16)

Country Link
US (1) US8372429B2 (pt)
EP (1) EP2233146B1 (pt)
JP (1) JPWO2009075216A1 (pt)
KR (1) KR101225898B1 (pt)
CN (1) CN101896187A (pt)
AU (1) AU2008336675B2 (pt)
BR (1) BRPI0821580A2 (pt)
CA (1) CA2707679A1 (pt)
ES (1) ES2546523T3 (pt)
HU (1) HUE027992T2 (pt)
MY (1) MY155591A (pt)
RU (1) RU2458695C2 (pt)
TR (1) TR201004707T1 (pt)
TW (1) TWI444190B (pt)
WO (1) WO2009075216A1 (pt)
ZA (1) ZA201003835B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101889677B1 (ko) * 2015-06-12 2018-08-17 제이에프이미네라르 가부시키가이샤 피부 창상 또는 피부 거침 치료제

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539306A (en) 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
JPS5030039B1 (pt) 1967-07-17 1975-09-27
JPS462280B1 (pt) 1966-07-25 1971-01-20
JP2811136B2 (ja) 1992-07-30 1998-10-15 財団法人生産開発科学研究所 シメチジン亜鉛錯体
DE69510254T2 (de) * 1994-03-25 1999-10-14 Kaisui Kagaku Kenkyujo Kk Antimikrobielles Mittel
JP3465248B2 (ja) * 1994-03-25 2003-11-10 株式会社海水化学研究所 抗微生物剤
AU701182B2 (en) * 1995-04-10 1999-01-21 Kyowa Chemical Industry Co., Ltd. Ultraviolet protective agent
JP3140408B2 (ja) * 1996-10-29 2001-03-05 協和化学工業株式会社 抗微生物剤
CZ297127B6 (cs) * 1997-07-04 2006-09-13 Kyowa Chemical Industry Co., Ltd. Syntetická pryskyricná kompozice odolná proti poskození teplem a její pouzití
JPH11222494A (ja) * 1997-11-21 1999-08-17 Sakai Chem Ind Co Ltd 金属錯体含有ハイドロタルサイト類化合物、抗菌剤、抗菌性樹脂組成物および抗菌性塗料組成物
JPH11240886A (ja) 1997-11-21 1999-09-07 Sakai Chem Ind Co Ltd 金属錯体含有ハイドロタルサイト類化合物、抗菌剤、抗菌性樹脂組成物および抗菌性塗料組成物
JPH11180808A (ja) * 1997-12-18 1999-07-06 Kyowa Chem Ind Co Ltd 藻発生または微小生物の繁殖抑制剤およびその使用
JP4004160B2 (ja) * 1998-09-21 2007-11-07 協和化学工業株式会社 ウラン（ｕ）含量の少ないハイドロタルサイト類化合物およびその製造法
JP4193044B2 (ja) * 2003-03-28 2008-12-10 戸田工業株式会社 Ｍｇ−Ｚｎ−Ａｌ系ハイドロタルサイト型粒子粉末及び該Ｍｇ−Ｚｎ−Ａｌ系ハイドロタルサイト型粒子粉末を用いた樹脂組成物
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
JP4154460B2 (ja) * 2006-11-09 2008-09-24 株式会社海水化学研究所 抗潰瘍剤
US8216608B2 (en) * 2006-12-20 2012-07-10 Kyowa Chemical Industry Co., Ltd. Gastric antacid

Also Published As

Publication number Publication date
TR201004707T1 (tr) 2010-11-22
AU2008336675A1 (en) 2009-06-18
JPWO2009075216A1 (ja) 2011-04-28
AU2008336675B2 (en) 2014-03-13
ZA201003835B (en) 2011-03-30
TWI444190B (zh) 2014-07-11
TW200938209A (en) 2009-09-16
HUE027992T2 (en) 2016-11-28
KR20100094991A (ko) 2010-08-27
CN101896187A (zh) 2010-11-24
EP2233146B1 (en) 2015-08-26
EP2233146A1 (en) 2010-09-29
MY155591A (en) 2015-11-13
EP2233146A4 (en) 2011-01-19
KR101225898B1 (ko) 2013-01-24
US8372429B2 (en) 2013-02-12
WO2009075216A1 (ja) 2009-06-18
CA2707679A1 (en) 2009-06-18
ES2546523T3 (es) 2015-09-24
RU2458695C2 (ru) 2012-08-20
RU2010128539A (ru) 2012-01-20
US20100323032A1 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
WO2007146491A3 (en) Flowable particulates
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
IL219268A (en) Anti-b79cd antibody, immunosuppressant and pharmacological agent that includes and uses it
HK1128251A1 (en) Fluid delivery devices, systems and methods
IL199216A (en) Monoclonal Antibodies Against 3angptl, Pharmaceuticals Containing Them and Their Uses
IL197831A (en) Human antibodies that bind 4cxcr, preparations containing them and their uses
EP2148117A4 (en) WAVE SEALING DEVICE AND VALVE STRUCTURE WITH THIS DEVICE
EP2199564A4 (en) FLUID INVERSION VALVE, EXHAUST GAS CONTROL VALVE COMPRISING SAME, AND VALVE VALVE WEST
NO343776B1 (no) Forbindelse som modulerer farmakokinetikkegenskaper til terapeutika, dens anvendelse i terapi og farmasøytisk sammensetning derav.
IL204607A0 (en) Antibodies against osteoclast - related protein siglec - 15, compositions comprising the same and uses thereof
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0807012A2 (pt) Uso de inseticidas, método de reduzir ou evitar o efeito fitotóxico de fungicidas, e, agente.
HK1140943A1 (en) Human antibodies that bind mesothelin, and uses thereof
BRPI0720169A2 (pt) Composto ou um sal do mesmo, prodroga, agente farmacêutico, método para a profilaxia ou tratamento de câncer, e, uso do composto
BRPI0718267A2 (pt) Máquina de formar, encher e selar.
BRPI0718587A2 (pt) Uso de um composto, compostos, método de tratamento ou prevenção de doenças, processos para a preparação do composto e composição farmacêutica contendo o mesmo
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
GB2451713B (en) Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
IL213043A0 (en) Lantibiotic carboxyamide derivatives, compositions comprising the same and uses thereof
HK1168016A1 (en) Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
ZA200900673B (en) 18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
EP2167490A4 (en) TRIAZOLE DERIVATIVES WITH ANTIPILY EFFECT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL